HOOKIPA Pharma
HOOK
HOOK was delisted on the 7th of August, 2025.
41 hedge funds and large institutions have $56.6M invested in HOOKIPA Pharma in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 13 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
31% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 13
14% more funds holding
Funds holding: 36 → 41 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.22% less ownership
Funds ownership: 3.36% → 3.14% (-0.22%)
36% less capital invested
Capital invested by funds: $88.7M → $56.6M (-$32.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$547K |
| 2 |
Northern Trust
Chicago,
Illinois
|
+$343K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$342K |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$312K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$299K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$2.29M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$2.11M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.91M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$453K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$329K |
HOOK Hedge Fund Activity: Q1 2020 in Review
41 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q1 2020, worth a combined $56.6M — down 36% from $88.7M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new HOOK positions and 2 closed out — a net gain of 5 holders — while 17 added to existing stakes and 13 trimmed.
The largest buyer was BlackRock, adding an estimated $547K. The largest seller was Artal Group, cutting an estimated $2.29M.
- 41 institutional investors held HOOKIPA Pharma (HOOK) as of Q1 2020, up from 36 in Q4 2019.
- Funds reported $56.6M of HOOKIPA Pharma stock for Q1 2020, down 36% quarter-over-quarter.
- 7 funds opened new HOOKIPA Pharma positions in Q1 2020 and 2 closed out, a net change of +5 holders.
- The largest HOOKIPA Pharma buyer in Q1 2020 was BlackRock, an estimated $547K added.
- The largest HOOKIPA Pharma seller in Q1 2020 was Artal Group, an estimated $2.29M sold.
Based on aggregated 13F filings for Q1 2020.